Assessment of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker on the split renal function in the patients with primary hypertension

Bilateral kidney damage in hypertensive patients is not parallel. Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB), as a commonly used antihypertensive drug, could protect kidney function and delay its deterioration. Most studies focused on overall renal function, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jingsi, Wang, Mingyu, Sun, Kehui, Ding, Yanchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136992/
https://www.ncbi.nlm.nih.gov/pubmed/34011065
http://dx.doi.org/10.1097/MD.0000000000025928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136992/
https://www.ncbi.nlm.nih.gov/pubmed/34011065
http://dx.doi.org/10.1097/MD.0000000000025928

Ejemplares similares